Charleston, SC -- (SBWIRE) -- 09/20/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: diaDexus, Inc. (OTCMKTS:DDXS), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), Komatsu Ltd (ADR) (OTCMKTS:KMTUY), Cellceutix Corp (OTCBB:CTIX)
diaDexus, Inc. (OTCMKTS:DDXS) increased +3.95% and closed at $1.58 on a traded volume of 244,460 shares, in comparison to 221,859 shares of average trading volume. So far this year, the stock is up over +364.71%.
The company has a total market capitalization of $85.65 million and its total outstanding shares are 54.21 million. diaDexus, Inc., a life sciences company, focuses on the development and commercialization of proprietary cardiovascular diagnostic products addressing needs in cardiovascular disease.
For How Long DDXS will Fight for Profitability? Read This Trend Analysis report
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) soared +0.71% and closed at $1.42 on a traded volume of 247,609 shares, whereas its average trading volume is 1.24 million shares. In the last three months, the stock is down -63.21%. The Intra-day range for the stock is $1.32 and $1.43.
Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Will NVIV Continue To Move Higher? Find Out Here
Komatsu Ltd (ADR) (OTCMKTS:KMTUY) dropped down -1.73% and closed at $26.15. So far in three months, the stock is up +5.08%. The 52-week range for the stock is $18.73 and $29.63 and during the previous trading session the stock touched its highest price at $26.20. Its introductory price for the day was $26.18, with the overall traded volume of 94,169 shares.
Komatsu Ltd. engages in the development, manufacture, marketing, and sale of various industrial-use products and services under the Komatsu brand worldwide. Its Construction, Mining, and Utility Equipment segment offers excavating equipment.
Has KMTUY Found The Bottom And Ready To Gain Momentum? Find Out Here
Cellceutix Corp (OTCBB:CTIX), after opening its shares at the price of $1.97, dropped -1.02% to close at $1.94 for the day. The stock moved on a traded volume of 368,569 shares, in comparison to 269,505 shares of average trading volume.
The 52-week range for the stock is $0.75 and $2.47 and during the previous trading session the stock touched its highest price at $1.97. Its introductory price for the day was $1.97. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Will CTIX Get Buyers Even After The Recent Rally? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)